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1. Introduction 
Atherosclerosis constitutes a primarily destructive phenomenon inherently arising from 
dynamics of pathobiologic effect within the intima of elastic and muscular arteries. It is 
significant to view the development of elevated intimal lesions within dimensions of 
ongoing further injury to the endothelium. 
Considerable interactivity evolves within plaques in consequence to neovascularization in 
particular. The outline evolution of individual atherosclerotic plaques would considerably 
modulate the dynamics of migration of smooth muscle cells to the intima and as a 
consequence of various agonists such as hypoxia, growth factors and coagulation-
anticoagulation-fibrinolysis systems. Also, insulin appears to exert toxicity on the vascular 
wall and possibly promote atherogenesis (Nandish et al., 2011). 
2. System pathways of injury 
System pathways constitute a representative sequence of events that depend on dysfunctional 
activation of endothelial cells. It is within scope of parameters of permeability and loss of 
endothelial cells that a full plethora of forms of injury converge as intimal cell proliferation and 
as deposition of protein matrix proteoglycans. Oxidative stress and chronic inflammation 
promote diabetes, hypertension and atherosclerosis (Sewon et al., 2011). 
The individual roles played by various agonist actions in the definition of the atherosclerotic 
plaque would evolve within the specificity of focal injury to the intima in particular. The 
convergence of such injuries appears a constitutive attribute of the variable expression of 
sequence prototypes in lesion demarcation. 
Developmental parameters of modelling include the delineation of individual pathogenic 
events in terms that integrally reconstitute the modified anatomy of the individual 
atherosclerotic plaque. In this regard, Ghrelin improves endothelial function, lowers blood 
pressure and regulates atherosclerosis (Zhang et al., 2011). 
Significance in terms of complicated plaques as constitutive pathways in modelling of 
plaques includes the essential interactivity of endothelium with smooth muscle cell trophic 
effect. Macrophages in particular implicate a series of converging events that sequentially 
re-define in repetitive form the dynamics of atherogenesis. Dyslipidemmia increases lipid 
content in foam cells found in atherosclerotic plaques (Wong et al., 2011). 
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Growth factors are instrumental in terms of the emerging morphologic features of the early 
atherosclerotic plaque and as derivative phenomena of endothelial injury and permeability. 
The constitutive parameters of re-distribution of trophic effect particularly interact with 
neovascularization within the plaque core. 
Developmental sequences of multifactorial type in atherogenesis are particularly prone to a 
staged outline evolution that permeates the intima and sustains injury to the endothelium. 
Such significant interactivity contributes to outline emergence of new sequences in trophic 
effect and as proliferation and migration of smooth muscle cells. 
The macrophage is central to such interactivity and operates primarily in chemotaxis and 
trophism, and also in terms that dominantly influence in significant fashion the attributes of 
lipid foam cells. Plant-derived alpha-linolenic acid, for example, restricts plaque T-cell 
proliferation, differentiation and inflammatory activity (Winnik et al., 2011). 
3. Focality of inflammation 
The inflammatory infiltrates include a representative response to injury as atherogenesis 
further compounds injury to the vascular intima. The role of endothelium is implicated as 
dysfunctional response with increased permeability to monocytes in particular. 
Proteoglycans retain lipoproteins subendothelially (Anggraeni et al., (2011). 
Such recruitment of novel forms of injury includes the transforming ability of protein matrix 
proteoglycans as integral constitution of the injurious agents. It is within the dimensional 
redistribution of such injury that the endothelium plays a prominent role in sequence 
selectivity and in modulation of parameters of redefinition of activated dysfunctional states 
of inflammatory cells within the plaque. 
The focality of injury is particularly significant within the neovascularized core of the 
individual plaque and as parameters in the growth and maturation of smooth muscle cells. 
Reparative processes allow for a sequential remodelling within such system pathways as 
coagulation and cellular migration within the vascular intima. 
The variability of delineation of injurious agents indicates an activation of new parameters 
as the plaque evolves. The overall confines further extend parameters in plaque modelling 
that permits responsive elements in the creation of multiple sequence pathways that evolve 
in their own right; for example, deletion of microsomal prostaglandin E2 synthase-1 retards 
atherogenesis (Wang et al., 2011). 
4. The individual smooth muscle cell/macrophage 
The secretory dynamics of smooth muscle cells and of macrophages attribute a central 
pathogenic role to foam cells within the intima. Both smooth muscle cells and macrophages 
are recognized source for foam cells that, in turn, predominate in the mature atheromatous 
plaque. On the other hand, the matrix proteoglycans are also central players in re-defining 
attributes of the injured endothelium. 
The reactivity of macrophages within the protein matrix that accumulate within the intima 
allows for the emergence of multiple converging agonists that characterize endothelial cell 
activation. The development of subsequent new forms of injury transforms such endothelial 
dysfunctionality as parameters of maturation of the plaque. Interleukin 18 is involved in 
plaque destabilization and regulates the innate immune response (Yamaoka-Tojo et al., 
2011). 
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The central core of the plaque is one dominated by influences exerted by transformations in 
terms of neovascularization and as compounded maturation leading to lipid core formation 
within the plaque. Insulin resistance and cardiovascular pathology may share a common 
genetic background (Bacci et al., 2011). 
It is highly significant to view the trophic attributes of injury to the endothelium as source of 
the evolutionary traits of emerging atherosclerotic plaques; indeed, Insulin-like growth 
factor-1 stabilizes the atherosclerotic plaque by altering smooth muscle phenotype (von der 
Thusen et al., 2011). Stages in sequence pathway maturation are central to the outline 
demarcation of individual plaques in a manner that depends integrally on dynamics of 
neovascularization of the plaque core. 
Hemodynamic shear stress contributes to a redistribution of actin microfilaments within 
endothelial cells in a manner that modulates dysfunctional issues of activated 
endothelium. 
5. Cellular proliferative kinetics 
A proliferative smooth muscle cellular response is further significant in the maturation of 
the atherosclerotic plaque within such sequence steps as redefined injury to the 
endothelium. 
Stages in preparation for subsequent events in the outline of the atherogenesis process 
would include the delivery of injurious agents to the intima. The sequence pathways are 
significant parametric factors in defining the dimensions of the endothelial participation in 
atherogenesis. Endoplasmic reticulum stress and the unfolded protein response characterize 
endothelial susceptibility to atherogenesis (Civelek et al., 2011). 
It is further to the evolving forms of agonist action that atherogenesis modifies in repeatedly 
staged sequence the pathways of dysfunctional activation of the endothelium. 
6. Low-density lipoproteins 
Neovascularization proves to be a centrally operative agonist in the modified development 
of atheroma formation and deposition. The added parameters of consequence appear to 
implicate a primarily evolutionary role for hypoxia and ischemia as plaque re-definition, 
both morphologically and in dysfunctional forms of endothelial activation. 
The inflammatory nature of the intimal deposits elicits a responsive panorama that 
implicates derivative attributes of low density lipoproteins and cholesterol and as extended 
participation of the neovascularization of the plaque. MicroRNA-29a targets lipoprotein 
lipase in oxidized low density lipoprotein and modulates cytokines and scavenger receptors 
(Chen et al., 2011) 
Hypoxia is itself essential for the formation of new vessels within the plaque with the 
production of growth factors and would additionally contribute to the intimal thickening as 
further evidence for staged representation of injury to the intima. 
Directional re-orientation of active dysfunctional states of endothelial cells compounds 
hypoxia and ischemia within the vascular intima. By-products of matrix proteoglycans and 
of lipid metabolism indicate the essential staging events in plaque maturation and as 
derivative phenomenon to further atherogenesis. Chemokines produced by endothelial cells 
are associated with leukocyte recruitment and angiogenesis in atherosclerosis (Speyer & 
Ward, 2011). 
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7. Intimal remodeling 
It is as remodelling of the injury to the intima that hypoxia and ischemia further modulate 
the migration of smooth muscle cells within the intima. The increased permeability of the 
endothelium is significant as a redefined series of further injuries to the underlying intima. 
The orientational redistribution of the agonists in atherogenesis redefine a central plaque 
contribution to increasing profiles of further hypoxia/ischemia and as evidential 
remounting of parameters of sequence effect. The multi-factorial injurious events are 
converging agonists in hypoxic/ischemic core regions of the individual atherosclerotic 
plaque. In such manner, the multi-staged evolution of plaques correlates with interactive 
dynamics of further injury within the intima. 
Dynamics of action of oxidized lipids correlate closely with emerging new roles for agonist 
action in developing plaques. The interaction of variably participating agonists contrast with 
the intimal emergence of incremental hypoxia/ischemia in terms of increasing matrix 
proteoglycan deposition and cellular proliferation of smooth muscle cells in particular. 
Atherosclerosis affecting different topographic sites correlate with the type of 
hyperlipidemia (Van Craeyveld et al., 2011). 
The platelet/coagulation systems are incremental sequence events as trophic influence in 
staged convergence of multiple agonists in intimal injury. 
Distributional parameters are particularly significant in the dimensional targeting of the 
intima in terms of the vasa vasorum supplying the arterial wall. 
Component systems of sequential impact would contribute to the emergence of positive 
feedback effect in agonist action. The endothelial cells participate by the production of 
various agents such as growth factors, in particular Platelet-Derived Growth Factor. The 
semblance of such influence dominantly re-characterizes the atherosclerotic plaque that 
trophically redefines the form of hypoxic/ischemic injury to the intima. miRNA –mediated 
epigenetic regulation may be implicated in atherogenesis, involving oxidized low-density 
lipoproteins (Chen et al., 2011). 
8. Hemodynamics 
Hemodynamics within the neovascularized core of the plaque allows for a developmental 
evolution in terms of so-called complications such as hemorrhage and rupture of the plaque 
and as staged representation of the endothelial cell injury. Consequential pathways of 
significance would confirm the agonist nature of hypoxia/ischemia in terms of further 
emergence of intimal deposition and of cellular proliferation and migration. 
A response to injury permits role redefinition as emerging parameters in pathogenesis of the 
deposition of proteoglycans within the vascular intima. Matrix metalloproteinases 
participate in plaque destabilization and rupture. Their overexpression is an independent 
factor in the pathogenesis of acute coronary syndromes (Kulach et al., 2010). A proliferative 
response in particular illustrates the nature of the vascular wall injury that incrementally 
progresses as gradients of hypoxia and ischemia within the vessel wall. 
9. Gradient parameters 
Consequential involvement of the lipid deposition phenomenon integrally permits the 
establishment of gradient parameters of hypoxia/ischemia within the operative fields of 
emerging neovascularization in the plaque core. 
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Procedural and technical specificity of individual plaques illustrate dynamic turnover 
within plaques in terms particularly of agonists and cellular parameters in redefinition of 
atherogenesis. In this regard, Interferon-alpha upregulates expression of scavenger-A in 
monocytes/macrophages with foam cell formation (Li et al., 2011). 
The specificity of the inflammatory response is sequentially consequent to the inter-
changeability of agonist-induced parameters in creating a microenvironment of hypoxia and 
ischemia centered on the intima. 
10. Cellular endothelial injury 
The contributing roles of endothelium especially in cases of trauma to the vessel wall 
would indicate the prototypical attributes in lesion emergence and of subsequent 
maturation of the atherogenesis phenomenon. Atherogenesis is contributory phenomenon 
to an ongoing migratory involvement of the intima. This is well-testified by smooth 
muscle cells that synthesize and secrete matrix proteoglycans, and oxidative stress also 
induces production of superoxide by endothelial cells with nitric oxide synthase 
uncoupling (Zweier et al., 2011). 
Significant participation in atherogenesis involves mirror-imaged targeting of multiple 
component systems within the vessel wall that developmentally integrate as regions of 
hypoxia and ischemia, including the thioredoxin system that correlates with cellular apoptosis 
in endothelial cell lines in hypoxic stress (Park et al., 2011). Neovascularization proves a 
permissive phenomenon in development of gradients of ischemia that redefine the individual 
plaque as compounding parameters of progression to further injury to the vascular wall. 
Permissive dynamics are characteristic of oxidation of lipids and particularly of low-density 
lipoproteins and as evolution of deposition within the intima. Targeting of subsets of cells 
indicates a selectivity process of progression within sequential pathways of incremental 
further injury to the vessel wall. Disrupted endoplasmic reticulum equilibrium engages the 
unfolded protein response in such cells as monocytes (Carroll et al., 2011). 
11. Vulnerability issues 
System reproduction indicates vulnerability selectivity in the evolution of atheromatous 
plaques in terms ranging from cell kinetics to proliferative migration of smooth muscle cells 
directed to the intima and a sensitivity of endothelial cells to responsive pathway generation 
and trophic factor production. The macrophage system is especially representative of novel 
pathway events that induce a sequential series of models in manipulative further 
compromise of viability of the endothelial cells. 
Within such scopes of pathogenic representation, there would emerge a parametric 
remodelling based on aberrant reconstitution of injury as further projected by responses to 
injury to the intima and endothelium. Within such context, the unfolded protein response is 
implicated in all stages of atherogenesis and plaque progression (Lhotak et al., 2011). 
12. Pathway activation 
The operative essentiality of the intimal involvement in atheroma formation calls into 
operation the developmental dimensions of both endothelium and also of medial smooth 
muscle cells. The sequence attributes of multiple different pathways contribute to the 
subsequent emergence of activation phenomena as well represented by the macrophage and 
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foam cell systems. Mast cells, macrophages and neutrophils release TNF-alpha, IFN-gamma 
and IL-6 with expression of adhesion molecules and leukocyte recruitment (Zhang et al., 
2011). Synthetic and contractile phenotypes of the individual smooth muscle cell indicate 
specialized forms of series determination in reconstitution of the damaged or injured 
subintima and also modelled parametric fashioning of the overlying endothelium. 
Hemodynamics of blood flow localizes such injured endothelium as representative and 
constitutive foci of persistent pathway activation that delivers dysfunctional attributes to the 
multi-components of the early atheromatous plaque. 
13. Eventual sequence emergence 
Contrasting sequentiality is triggered by an aberrant selectivity for trophic effect 
reproduction in terms of ongoing creation of hypoxia/ischemic gradients across both the 
endothelium lining the vascular lumen and also within critical regions of operative effect in 
the involved vascular intima. Such representation calls into evidence gradient pathways of 
projected reproduction that specifically induce focality of involvement of the plaque within 
systems of cascade effect. A complex interaction of genetic and environmental factors 
operates (Chyu & Shah, 2011) 
The platelet and coagulation systems conclusively demonstrate a participating series of roles 
culminating in organization of adherent thrombus within the plaque as incorporated 
dynamics of trophic potential.  
Incremental attributes of further compromise of the viability of the intima are demonstrable 
as evidential pathways of increasing impact in terms of enhanced intimal thickness. In this 
regard, cells proliferate in atherosclerotic lesions and also in vascular tissue bordering the 
plaque (Zettler et al., 2010). 
Scope of representative projection is conclusively constituted by the end-stage plaque with a 
central atheromatous core that consists of cholesterol lipid, lipoprotein and oxidized 
molecular entities of variable derivation. Increasing representation of inflammatory 
dynamics is largely dependent on initiating events within the foci of intima underlying 
dysfunctionally activated endothelium. The dynamics of spread and of replication of 
individual endothelial cells constitutes a further pathway model for gradient creation 
between flowing blood and vascular wall intima. Pancoronary arterial instability implicates 
multifocal disease in acute coronary syndromes (Puri et al., 2011). 
14. Concluding remarks 
Re-distribution and retargeting events are primary modelling systems in sequence pathways 
and as multi-staged involvement of the intima of arterial vessel walls. The intimal thickness 
and remodelling of pathways allow for incremental redistribution of agonists that target 
differential systems such as endothelium and smooth muscle cells. Macrophages are 
constitutive systemic parameters that focally re-orientate the targeting dynamics of hypoxia 
and ischemia in intimal lesion creation. Oxidation-specific epitopes present on apoptotic 
cells induce the selection of Pattern Recognition Receptors and damage-associated 
molecular patterns that may be targeted by innate immunity (Miller et al., 2011). 
Only in terms of ensuing neovascularization of the individual atherosclerotic plaque can 
system specificity in atherogenesis permit the emergence of converging pathways of injury 
and attempted reconstitution of the vessel wall and endothelium. 
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Macrophages induce transformational events within micro-environmental conditions of 
propagated susceptibility patterns that relate in particular to selective sites of vascular 
involvement such as near-arterial branch points of exit. It is such representation that 
illustrates the evolving vulnerability of focal sites of intima and endothelium in the 
generation of multiple atheromatous plaques; these subsequently promote self-involvement 
in dynamic transformation to the so-called complicated plaque. 
Regional pathways of spread and further expansion contrast with the maturation of plaque 
morphology within such systems as macrophage and endothelial cell activation, with the 
creation of the synthetic/secretory phenotype of the individual smooth muscle cell within 
the intima. 
Distributional dynamics in generation of the atheromatous plaque are developmental issues 
as indicated by activation of the proto-oncogenes c-fos and c-myc. The considerable 
heterogeneity of component cell subpopulations within any atheromatous plaque also 
permits the emergence of monoclonal groups of smooth muscle cells that trophically sustain 
growth of the plaque within dimensional confines of the involved intima and of injured 
overlying endothelium. 
Hypoxia-ischemia is a powerful component series of systems in evolution of the 
susceptibility pattern determination of plaque localization and remodelling, as well-typified 
by the marked eventual thickening of the involved intima.  
Gradient generation is a key mechanistic system in generation of projected effects of 
hypoxia-ischemia that coordinate the convergence of injurious agonists in terms of trophic 
and destructive elements within the intima of the arterial wall. 
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